MiYOSMART
THE INNOVATION IN SPECTACLE LENSES
A SAFE, EFFECTIVE AND NON-INVASIVE WAY TO MANAGE MYOPIA IN CHILDREN
0
%
60% SLOW-DOWN IN MYOPIA PROGRESSION*
0
+
EYE SPECIALISTS IN SWITZERLAND
Why MiYOSMART
⠀
A safe, effective and non-invasive method
No negative observations were reported during clinical testing involving two years of wear. Highly effective myopia management method. Suitable for children aged 6 to 18 following consultation with your eye specialist.
⠀
An award-winning lens with innovative D.I.M.S. technology
In 2018, MiYOSMART won the Grand Prize, Grand Award and Special Gold Medal at the International Exhibition of Inventions in Geneva, Switzerland. In 2020, MiYOSMART received the Silmo d’Or award at the Silmo trade fair in Paris.
⠀
Appreciated by parents
Regular check-ups with eye specialists ensure that children get optimal care. Wearing MiYOSMART spectacle lenses every day is another key factor in successful myopia management.
⠀
Special manufacturer services
- Free lens replacement during the first year if visual acuity changes by at least 0.5 dioptres.
- 50% discount on any new order during the first year in the event of material breakage, chipping at the edges or scratches in the centre.
- One-off 50% discount during the first year in cases of anatomical necessity.
How children see the world
Discover the myopia simulator and experience how short-sighted children see the world.
What is short-sightedness (myopia)?
Nothing is more important than your child’s health and well-being. You want your child to develop well – now and in the future. If you have noticed that your child cannot see clearly at a distance, making it harder for them to concentrate at school and restricting them during play, your child might have myopia (short-sightedness). If left uncorrected in children, myopia can lead to permanent visual impairment.*
Short-sightedness will most likely become more and more common in the future, due to the rise in digitalisation and changes in children’s lifestyles. For instance, children are increasingly using digital devices, reading and learning on PCs, and spending less of their free time outdoors. Genetic predisposition and environmental factors also play a role.**
* The impact of myopia and high myopia: report of the Joint World Health Organization-Brien Holden Vision Institute Global Scientific Meeting on Myopia, University of New South Wales, Sydney, Australia, 16-18 March 2015. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO. Link: https://www.who.int/blindness/causes/MyopiaReportforWeb.pdf
** Source: Wolffsohn JS, Flitcroft DI, Gifford KL, et al. IMI – Myopia control reports overview and introduction. Invest Ophthalmol Vis Sci. 2019;60:M1-M19. https://doi.org/10.1167/iovs.18-25980
⠀
Myopia figures on the rise
The increase in short-sightedness is a worldwide problem.
By 2050, 5 billion people, or 50% of the world’s population, are expected to be affected by short-sightedness.*
* Holden B.A., Fricke T.R., Wilson D.A., Jong M., Naidoo K.S., Sankaridurg P., Wong T.Y., Naduvilath T.J., Resniko S. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. American Academy of Ophthalmology. 05/2016, vol. 123, no. 5, p. 1036-1042. https://doi.org/10.1016/j.ophtha.2016.01.006
How the D.I.M.S. technology from MiYOSMART works
According to a study by the Hong Kong Polytechnic University, the progression of short-sightedness (myopia) can be slowed if two focal strengths are offered permanently, with incorporated myopic defocus.
The effectiveness of MiYOSMART’s D.I.M.S. Technology in slowing myopia progression has been proven in a clinical study.* As a result, in 2018, at the 46th International Exhibition of Inventions in Geneva, Switzerland, this technology won three prestigious awards: the Grand Prize, Grand Award and Special Gold Medal. In 2020, the successful implementation of this technology also earned it the Silmo d’Or award in the ‘Vision’ category.
* Lam CSY, Tang WC, Tse DY, Lee RPK, Chun RKM, Hasegawa K, Qi H, Hatanaka T, To CH. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomized clinical trial. British Journal of Ophthalmology. Published Online First: 29 May 2019. doi: 10.1136/bjophthalmol-2018-313739
⠀
MiYOSMART with D.I.M.S. Technology is a single-vision lens, whose front surface contains hundreds of small segments, all of which have an incorporated myopic defocus. This guarantees that when the eye looks through an area the size of a pupil, it will always see a sharp image and a defocussed image. At the same time, the structure of the spectacle lens helps slow excessive axial length growth in the eye and provides clear vision.
Treating short-sightedness
On 11 March 2023, the Swiss television show ‘Gesundheit heute’ (Health Today) reported on the treatment of short-sightedness in children.
Feedback and opinions
Renowned eye specialists have worked with MiYOSMART